<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   2868
  </number>
  <updateDate>
   2023-01-11T13:48:33Z
  </updateDate>
  <updateDateIncludingText>
   2023-01-11T13:48:33Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-04-28
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 73 (Wednesday, April 28, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. BUTTERFIELD:H.R. 2868.Congress has the power to enact this legislation pursuantto the following:Under Article I, Section 8, Clause 3 of the Constitution,Congress has the power to collect taxes and expend funds toprovide for the general welfare of the United States.Congress may also make laws that are necessary and proper forcarrying into execution their powers enumerated under ArticleI.[Page H2127]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hsif00
    </systemCode>
    <name>
     Energy and Commerce Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-04-29T17:50:36Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-04-28T22:05:00Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <actions>
   <item>
    <actionDate>
     2021-04-29
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Health.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-04-28
    </actionDate>
    <text>
     Referred to the House Committee on Energy and Commerce.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsif00
      </systemCode>
      <name>
       Energy and Commerce Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-04-28
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-04-28
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     B001251
    </bioguideId>
    <fullName>
     Rep. Butterfield, G. K. [D-NC-1]
    </fullName>
    <firstName>
     G. K.
    </firstName>
    <lastName>
     Butterfield
    </lastName>
    <party>
     D
    </party>
    <state>
     NC
    </state>
    <district>
     1
    </district>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <cosponsors>
   <item>
    <bioguideId>
     L000576
    </bioguideId>
    <fullName>
     Rep. Long, Billy [R-MO-7]
    </fullName>
    <firstName>
     Billy
    </firstName>
    <lastName>
     Long
    </lastName>
    <party>
     R
    </party>
    <state>
     MO
    </state>
    <district>
     7
    </district>
    <sponsorshipDate>
     2021-04-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
  </cosponsors>
  <policyArea>
   <name>
    Health
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects>
    <item>
     <name>
      Home and outpatient care
     </name>
    </item>
    <item>
     <name>
      Inflation and prices
     </name>
    </item>
    <item>
     <name>
      Medicaid
     </name>
    </item>
    <item>
     <name>
      Prescription drugs
     </name>
    </item>
    <item>
     <name>
      State and local government operations
     </name>
    </item>
   </legislativeSubjects>
   <policyArea>
    <name>
     Health
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-04-28
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2021-06-15T16:15:44Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;b&gt;Protecting Access to Affordable Medicines Act of &lt;/b&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill prohibits additional rebates for certain drugs under the Medicaid Drug Rebate Program. Specifically, the bill prohibits additional rebates with respect to noninnovator multiple-source drugs (i.e., generics) for which the average manufacturer price is less than $1. &lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   Protecting Access to Affordable Medicines Act of 2021
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     Protecting Access to Affordable Medicines Act of 2021
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To amend title XIX of the Social Security Act to prohibit additional rebates under the Medicaid program for certain noninnovator multiple source drugs.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     Protecting Access to Affordable Medicines Act of 2021
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-04-28T04:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr2868ih/xml/BILLS-117hr2868ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-04-29
   </actionDate>
   <text>
    Referred to the Subcommittee on Health.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

2021-04-29
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-04-28
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the House Committee on Energy and Commerce.
IntroReferral
Intro-H
2021-04-28
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-04-28
9
Library of Congress
Introduced in House
IntroReferral
2021-04-28T22:05:00Z
Referred to
House
Energy and Commerce Committee
2021-04-29T17:50:36Z
Referred to
Health Subcommittee
hsif14
hsif00
Standing
L000576
7
Billy
Rep. Long, Billy [R-MO-7]
Long
R
2021-04-28
MO
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-04-28
2021-04-29
Referred to the Subcommittee on Health.
House
Health
B001251
1
G. K.
Rep. Butterfield, G. K. [D-NC-1]
N
Butterfield
D
NC
Home and outpatient care Inflation and prices Medicaid Prescription drugs State and local government operations
2021-04-28
Introduced in House
 <p><b>Protecting Access to Affordable Medicines Act of </b><b>2021</b></p> <p>This bill prohibits additional rebates for certain drugs under the Medicaid Drug Rebate Program. Specifically, the bill prohibits additional rebates with respect to noninnovator multiple-source drugs (i.e., generics) for which the average manufacturer price is less than $1. </p>
2021-06-15T16:15:44Z
00
2021-04-28T04:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr2868ih/xml/BILLS-117hr2868ih.xml
Protecting Access to Affordable Medicines Act of 2021
Protecting Access to Affordable Medicines Act of 2021
Display Title
IH
Introduced in House
To amend title XIX of the Social Security Act to prohibit additional rebates under the Medicaid program for certain noninnovator multiple source drugs.
Official Title as Introduced
IH
Introduced in House
Protecting Access to Affordable Medicines Act of 2021
Short Title(s) as Introduced
HR
2023-01-11T13:48:33Z
2023-01-11T13:48:33Z
3.0.0
2021-04-29
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-04-28
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the House Committee on Energy and Commerce.
IntroReferral
Intro-H
2021-04-28
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-04-28
9
Library of Congress
Introduced in House
IntroReferral
B001251
1
G. K.
Rep. Butterfield, G. K. [D-NC-1]
N
Butterfield
D
NC
L000576
7
Billy
Rep. Long, Billy [R-MO-7]
Long
R
2021-04-28
MO
Home and outpatient care Inflation and prices Medicaid Prescription drugs State and local government operations
2021-04-28
Introduced in House
 <p><b>Protecting Access to Affordable Medicines Act of </b><b>2021</b></p> <p>This bill prohibits additional rebates for certain drugs under the Medicaid Drug Rebate Program. Specifically, the bill prohibits additional rebates with respect to noninnovator multiple-source drugs (i.e., generics) for which the average manufacturer price is less than $1. </p>
2021-06-15T16:15:44Z
00
Protecting Access to Affordable Medicines Act of 2021
Protecting Access to Affordable Medicines Act of 2021
Display Title
IH
Introduced in House
To amend title XIX of the Social Security Act to prohibit additional rebates under the Medicaid program for certain noninnovator multiple source drugs.
Official Title as Introduced
IH
Introduced in House
Protecting Access to Affordable Medicines Act of 2021
Short Title(s) as Introduced
2021-04-29
Referred to the Subcommittee on Health.